Equites Radar

OPCH · Option Care Health, Inc.

Medical Care FacilitiesUnited StatesAnalyst view: Buy

$21.66

+3.07% last session

End-of-day data · updated 2026-07-28

Neutral2 bullish · 2 bearish technical signals
Consensus: Buy (1.92 from 12 analysts)
To mean target: +29.6%

Market cap

$3B

Enterprise value

$5B

Trailing P/E

17.0

Forward P/E

10.7

Dividend yield

Beta

0.65

Avg volume

3M

Employees

7K

2D change

5D change

3.46%

10D change

0.32%

30D change

-0.05%

60D change

4.50%

MTD change

3.66%

YTD change

-31.54%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.92
Covering analysts12
Mean price target$28.08
Low price target$22.00
Upside to mean target+29.6%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)58.9
50-day MA$21.27
200-day MA$27.76
Price vs 50-day MA+5.7%
Price vs 200-day MA-19.0%
MACD histogram0.05
Volume vs 3-month avg1.2×
52w low $19.5252w high $36.59

Analyst sentiment over time — OPCH

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-17

Latest call per bank · past 12 months

Goldman Sachs

Neutral

$22.00

+1.6% vs price
▲ raised from $0.00Initiates · 2026-06-08

Morgan Stanley

Overweight

$485

+2139.2% vs price
▲ raised from $0.00Maintains · 2026-05-06

JP Morgan

Overweight

$33.00

+52.4% vs price
▼ cut from $40.00Maintains · 2026-05-04

UBS

Buy

$39.00

+80.1% vs price
▼ cut from $45.00Maintains · 2026-05-01

Bank of America

Buy

$35.00

+61.6% vs price
▲ raised from $32.00Maintains · 2025-12-09

Deutsche Bank

Buy

$36.00

+66.2% vs price
▲ raised from $31.00Maintains · 2025-12-09

Recent rating actions

DateFirmActionRatingPrice target
2026-07-17Stephens & Co.DowngradeOverweightEqual-Weight$30.00 $24.00
2026-06-08Goldman SachsInitiatesNeutral$0.00 $22.00
2026-05-06Morgan StanleyMaintainsOverweight$0.00 $485
2026-05-04JP MorganMaintainsOverweight$40.00 $33.00
2026-05-01Barrington ResearchMaintainsOutperform$42.00 $32.00
2026-05-01UBSMaintainsBuy$45.00 $39.00
2026-05-01TD CowenMaintainsHold$37.00 $23.00
2026-01-16Barrington ResearchMaintainsOutperform$38.00 $42.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 59 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 5.7% above the 50-day MA ($21.27).
  • Price vs 200-day MA: Trading 19.0% below the 200-day MA ($27.76).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is positive (+0.05) — short-term momentum is improving.
  • 52-week range: Price sits between the 52-week low ($19.52) and high ($36.59).

OPCH Price Chart

Loading chart for OPCH

Fundamentals

Revenue (TTM)$6.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$8.61
Net debt / EBITDA2.7
WACC8.0%
Revenue growth1.00%
Earnings growth3.00%

About Option Care Health, Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

More in Medical Care Facilities

Screen OPCH against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.